Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone

Pharmacopsychiatry

Volumn 35, Issue 3, 2002, Pages 116-118

  Kohnke M D ^a   Griese, E U ^b   Stosser D ^a   Gaertner, I ^a   Barth, G ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; CYTOCHROME P450 2D6; HALOPERIDOL; PALIPERIDONE; RISPERIDONE;

ADOLESCENT; ARTICLE; CASE REPORT; CYTOCHROME P450 2D6 DEFICIENCY; DRUG HALF LIFE; ENZYME DEFICIENCY; ENZYME METABOLISM; EXTRAPYRAMIDAL SYMPTOM; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CYTOCHROME P-450 CYP2D6; HUMANS; MALE; RISPERIDONE; SCHIZOPHRENIA;

EID: 0036086164     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-31517     Document Type: Article

References (15)

1. A pilot study on risperidone metabolism: The role of cytochromes P450 2D6 and 3A
2. The cytochrome P450 2D6 (2YP2D6) enzyme polymorphism: Screening costs and influence on clinical outcomes in psychiatry
3. Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
4. The genetic polymorphism of debrisoquine/sparteine metabolism-clinical aspects
5. Pharmacokinetics and drug interactions: Update for new antipsychotics
6. Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4
7. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population
8. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactine response in healthy subjects
9. Polymorphic hydroxylation of Debrisoquine in man
10. Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone
11. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: A prospective study
12. Rapid detection of CYP2D6 null alleles by long distance- and multiplex-polymerase chain reaction
13. The regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat
14. Effects of itraconazole on the steady-state plasma concentrations of haloperidol and its reduced metabolite in schizophrenic patients: In vivo evidence of the involvement of CYP3A4 for haloperidol metabolism